SB352 HFA Griffith 3-8

Altizer – 3259

Amd to Summers – Burkhammer Amd

Delegate Griffith moves to amend "SB352 HFA Summers and Burkhammer 3-8 #2" on page 5, Section 3, line 49, following the words "on reversal" by inserting a comma and the words "including the risks associated with reversal and its current status of federal Food and Drug Administration approval."